Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
105.15
+0.47 (0.45%)
Jan 22, 2026, 3:04 PM EST - Market open

Incyte Revenue

Incyte had revenue of $1.37B in the quarter ending September 30, 2025, with 20.05% growth. This brings the company's revenue in the last twelve months to $4.81B, up 18.09% year-over-year. In the year 2024, Incyte had annual revenue of $4.24B with 14.76% growth.

Revenue (ttm)
$4.81B
Revenue Growth
+18.09%
P/S Ratio
4.22
Revenue / Employee
$1,839,169
Employees
2,617
Market Cap
20.64B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 20181.88B345.67M22.50%
Dec 31, 20171.54B430.50M38.93%
Dec 31, 20161.11B351.97M46.70%
Dec 31, 2015753.75M242.26M47.36%
Dec 31, 2014511.50M508.45M16,696.72%
Dec 31, 20133.05M-294.01M-98.97%
Dec 31, 2012297.06M202.60M214.50%
Dec 31, 201194.46M-75.42M-44.40%
Dec 31, 2010169.88M160.61M1,733.55%
Dec 31, 20099.27M5.35M136.41%
Dec 31, 20083.92M-30.52M-88.62%
Dec 31, 200734.44M6.80M24.59%
Dec 31, 200627.64M19.80M252.32%
Dec 31, 20057.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genmab3.85B
BioNTech SE3.70B
Royalty Pharma2.35B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
Insmed447.02M
BridgeBio Pharma353.78M
Revenue Rankings